298 related articles for article (PubMed ID: 33539329)
41. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
[TBL] [Abstract][Full Text] [Related]
42. Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration.
Fan Y; Liu B; Chen F; Song Z; Han B; Meng Y; Hou J; Cao P; Chang Y; Tan K
Front Immunol; 2021; 12():612144. PubMed ID: 33868231
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma.
Xu Z; Xiang L; Peng L; Gu H; Wang Y
Comput Math Methods Med; 2022; 2022():3445230. PubMed ID: 36148016
[TBL] [Abstract][Full Text] [Related]
44. Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
Huang Z; Yang H; Lao J; Deng W
PLoS One; 2023; 18(7):e0287303. PubMed ID: 37467193
[TBL] [Abstract][Full Text] [Related]
45. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis.
Lu Y; Yu J; Dong Q; Du Y; Liang Z
Int J Gen Med; 2022; 15():6127-6143. PubMed ID: 35846794
[TBL] [Abstract][Full Text] [Related]
46. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
[TBL] [Abstract][Full Text] [Related]
47. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
[TBL] [Abstract][Full Text] [Related]
48. ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer.
Zhang J; Wang H; Yuan C; Wu J; Xu J; Chen S; Zhang C; He Y
Front Cell Dev Biol; 2022; 10():808212. PubMed ID: 35399517
[TBL] [Abstract][Full Text] [Related]
49. Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma.
Wu B; Fu L; Guo X; Hu H; Li Y; Shi Y; Zhang Y; Han S; Lv C; Tian Y
Front Immunol; 2023; 14():984816. PubMed ID: 36761750
[TBL] [Abstract][Full Text] [Related]
50. Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment.
Huang J; Zhou L; Deng K
J Ovarian Res; 2023 Apr; 16(1):64. PubMed ID: 37005667
[TBL] [Abstract][Full Text] [Related]
51. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment.
Yao K; Wei L; Zhang J; Wang C; Wang C; Qin C; Li S
Aging (Albany NY); 2020 Aug; 12(16):16238-16254. PubMed ID: 32833670
[TBL] [Abstract][Full Text] [Related]
52. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
53. PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma.
Wen Y; Wang Y; Huang Y; Liu Z; Hui C
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7139-7153. PubMed ID: 36884119
[TBL] [Abstract][Full Text] [Related]
54. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
Yang Y; Gao Y; Liu XS; Huang ZM; Zhang Y; Zhang YH; Liu ZY; Chen YX; Pei ZJ
Exp Ther Med; 2024 Aug; 28(2):305. PubMed ID: 38873045
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive analysis of cell-extracellular matrix protein Ras suppressor-1 in function and prognosis of gastrointestinal cancers.
Xu Y; Hou YY; Wu Z; Fang ZX; Wu HT; Liu J
World J Methodol; 2023 Sep; 13(4):223-237. PubMed ID: 37771863
[TBL] [Abstract][Full Text] [Related]
56. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
Liu T; Wu H; Qi J; Qin C; Zhu Q
Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
[TBL] [Abstract][Full Text] [Related]
57. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
[TBL] [Abstract][Full Text] [Related]
58. Prognostic potential of PRPF3 in hepatocellular carcinoma.
Liu Y; Yang Y; Luo Y; Wang J; Lu X; Yang Z; Yang J
Aging (Albany NY); 2020 Jan; 12(1):912-930. PubMed ID: 31926109
[TBL] [Abstract][Full Text] [Related]
59. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
Wu Z; Wang YM; Dai Y; Chen LA
Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of immune-related cells and genes in the tumor microenvironment of ovarian cancer, especially CST4.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Life Sci; 2021 Jul; 277():119461. PubMed ID: 33811900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
